278 related articles for article (PubMed ID: 9589883)
1. [Prostate cancer with high serum level of CEA and CA19-9: a case report].
Momma T; Kimura S; Saito S; Onoda N
Hinyokika Kiyo; 1998 Mar; 44(3):187-91. PubMed ID: 9589883
[TBL] [Abstract][Full Text] [Related]
2. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
Yokoyama S; Fukuhara S; Imazu T; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
[TBL] [Abstract][Full Text] [Related]
3. [A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
Sugaya Y; Ochi M; Hashimoto S; Muraki J; Morita T; Kobayashi Y; Nakamura S; Tokue A
Hinyokika Kiyo; 1997 Jul; 43(7):495-9. PubMed ID: 9282296
[TBL] [Abstract][Full Text] [Related]
4. [Adenocarcinoma of the bladder producing carcinoembryonic antigen and carbohydrate antigen 19-9: report of a case].
Iwaki H; Omatsu S; Konishi T; Moritani S
Hinyokika Kiyo; 1997 May; 43(5):355-8. PubMed ID: 9208321
[TBL] [Abstract][Full Text] [Related]
5. [Prostatic cancer in a young adult: a report of 2 cases].
Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
[TBL] [Abstract][Full Text] [Related]
6. [A case of CEA-producing renal pelvic and ureteral cancer].
Abe T; Konari S; Ogata M; Komatsu S; Satoh T
Hinyokika Kiyo; 2003 Feb; 49(2):75-9. PubMed ID: 12696186
[TBL] [Abstract][Full Text] [Related]
7. [A case of primary transitional cell carcinoma of the prostate].
Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
[TBL] [Abstract][Full Text] [Related]
8. [Prostate cancer with penile metastasis: a case report].
Sawada A; Segawa T; Nakanishi S; Kinoshita H; Yamamoto S; Kamoto T; Ogawa O
Hinyokika Kiyo; 2005 Nov; 51(11):771-3. PubMed ID: 16363713
[TBL] [Abstract][Full Text] [Related]
9. [A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
Matsuoka Y; Ishimaru H; Arai G; Aida J; Okada Y; Ito Y
Hinyokika Kiyo; 2004 Sep; 50(9):637-40. PubMed ID: 15518131
[TBL] [Abstract][Full Text] [Related]
10. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
11. [Small cell carcinoma of the prostate: a case report].
Yamamoto N; Kinoshita H; Inoue T; Kawakita S; Oguchi N; Muguruma K; Kawa G; Sakaguchi Y; Adachi Y; Sakaida N; Uemura Y; Matsuda T
Hinyokika Kiyo; 2007 Sep; 53(9):665-9. PubMed ID: 17933147
[TBL] [Abstract][Full Text] [Related]
12. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
Grotowski M; Maruszyński M; Piechota W
Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
[TBL] [Abstract][Full Text] [Related]
14. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
15. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
16. Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml.
Persec Z; Persec J; Sović T; Romic Z; Bosnar Herak M; Hrgovic Z
Onkologie; 2010; 33(3):110-2. PubMed ID: 20215802
[TBL] [Abstract][Full Text] [Related]
17. The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
[TBL] [Abstract][Full Text] [Related]
18. Serum tumor markers in skeletal metastasis.
Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
[TBL] [Abstract][Full Text] [Related]
19. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
[TBL] [Abstract][Full Text] [Related]
20. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
